Nasdaq

EDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES FDA APPROVAL FOR DEGENERATIVE MITRAL REGURGITATION

IRVINE, Calif., Sept. 15, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transcatheter valve repair system for transcatheter ...
Nasdaq

Edwards PASCAL Transcatheter Valve Repair System Receives European Approval For Tricuspid Repair

IRVINE, Calif., May 18, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, ...
Newswire

EDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES HEALTH CANADA APPROVAL FOR SIGNIFICANT, SYMPTOMATIC MITRAL REGURGITATION

TORONTO, July 12, 2024 /CNW/ - Edwards Lifesciences (Canada) Inc today announced Health Canada's approval of the company's PASCAL Precision transcatheter valve repair system for the percutaneous ...
Medscape

PASCAL Mitral Valve Repair Shines at 2 Years in CLASP

Transcatheter mitral valve repair with the PASCAL device showed high rates of survival and freedom from heart failure rehospitalization at 2 years in the single-arm, safety and efficacy CLASP study.
Oklahoma's News

EDWARDS PASCAL PRECISION TRANSCATHETER MITRAL AND TRICUSPID VALVE REPAIR SYSTEM RECEIVES CE MARK

IRVINE, Calif., Aug. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transcatheter valve repair system received CE Mark for the ...

Philips wins FDA clearance for imaging device developed with Edwards

Philips said Thursday it has received 510(k) clearance for a heart procedure visualization tool it developed with Edwards ...
MedPage Today

Passing Early-Term Report Cards for New Mitral, Tricuspid Valve Interventions

Progress continues to be made on new transcatheter devices for the treatment of severe mitral and tricuspid regurgitation, investigators reported. Several valve repair and replacement technologies, ...
TCTMD

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

Hausleiter J. First commercial multicenter experience with the PASCAL transcatheter valve repair system for tricuspid regurgitation. Presented at: TVT 2021. July 21. 2021. Miami, FL. MIAMI, FL—The ...
EurekAlert!

Novel TEER repair device meets primary endpoint in treating degenerative mitral regurgitation in patients not eligible for surgery

BOSTON – September 17, 2022 – Results of the first randomized controlled trial to directly compare two contemporary transcatheter edge-to-edge repair (TEER) devices for degenerative mitral ...
Healio

Transcatheter valve repair system for tricuspid regurgitation improves outcomes at 1 year

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “A minimally invasive, transcatheter leaflet strategy ...
Healio

Transcatheter mitral valve repair system safe, effective at 6 months

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PHILADELPHIA — Six-month data from the CLASP study ...